WJA
BPTH

Willis Johnson & Associates’s Bio-Path Holdings Inc BPTH Stock Holding History

Willis Johnson & Associates’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-569
Closed -$40K – 98
2020
Q4 		$40K Buy
+569
New +$42.7K 0.01% 83

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HI
Human Investing Lake Oswego, Oregon $771M AUM 18.84% 1-Year Est. Return

Willis Johnson & Associates's BPTH Position: Q1 2021 in Review

Willis Johnson & Associates sold out of Bio-Path Holdings Inc (BPTH) in Q1 2021, closing a stake of 569 shares — an estimated $40K sold.

Willis Johnson & Associates first reported a position in BPTH in Q4 2020 and held it in 1 quarter. The position peaked at $40K in Q4 2020. 19 funds tracked by Wall St. Rank hold BPTH as of Q1 2021.

  • Willis Johnson & Associates reported no remaining Bio-Path Holdings Inc position as of Q1 2021 after selling out during the quarter.
  • Willis Johnson & Associates sold 569 Bio-Path Holdings Inc shares in Q1 2021, an estimated $40K.
  • Willis Johnson & Associates first reported a position in Bio-Path Holdings Inc in Q4 2020 and held it in 1 quarter.
  • Willis Johnson & Associates's Bio-Path Holdings Inc position peaked at $40K in Q4 2020.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2021.

Based on Willis Johnson & Associates's 13F filing for Q1 2021, filed 29 Apr 2021.